nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—Growth retardation—Dactinomycin—muscle cancer	0.0429	0.073	CcSEcCtD
Acetazolamide—Hepatic insufficiency—Methotrexate—muscle cancer	0.0273	0.0465	CcSEcCtD
Acetazolamide—AQP1—smooth muscle tissue—muscle cancer	0.0208	0.0504	CbGeAlD
Acetazolamide—AQP1—renal system—muscle cancer	0.02	0.0485	CbGeAlD
Acetazolamide—AQP1—cardiac atrium—muscle cancer	0.0179	0.0435	CbGeAlD
Acetazolamide—Metabolic acidosis—Etoposide—muscle cancer	0.0178	0.0303	CcSEcCtD
Acetazolamide—CA7—renal system—muscle cancer	0.016	0.0388	CbGeAlD
Acetazolamide—AQP1—tendon—muscle cancer	0.0156	0.0379	CbGeAlD
Acetazolamide—AQP1—bone marrow—muscle cancer	0.0151	0.0367	CbGeAlD
Acetazolamide—AQP1—vagina—muscle cancer	0.0145	0.0352	CbGeAlD
Acetazolamide—AQP1—head—muscle cancer	0.0134	0.0325	CbGeAlD
Acetazolamide—CA3—cardiac atrium—muscle cancer	0.0131	0.0319	CbGeAlD
Acetazolamide—AQP1—testis—muscle cancer	0.0129	0.0314	CbGeAlD
Acetazolamide—Reaction gastrointestinal—Methotrexate—muscle cancer	0.0127	0.0215	CcSEcCtD
Acetazolamide—CA14—cardiac atrium—muscle cancer	0.0119	0.0289	CbGeAlD
Acetazolamide—CA3—tendon—muscle cancer	0.0114	0.0278	CbGeAlD
Acetazolamide—CA3—bone marrow—muscle cancer	0.0111	0.0269	CbGeAlD
Acetazolamide—CA9—tendon—muscle cancer	0.011	0.0266	CbGeAlD
Acetazolamide—CA3—vagina—muscle cancer	0.0106	0.0258	CbGeAlD
Acetazolamide—Numbness—Vincristine—muscle cancer	0.0105	0.0179	CcSEcCtD
Acetazolamide—CA14—tendon—muscle cancer	0.0104	0.0252	CbGeAlD
Acetazolamide—CA12—renal system—muscle cancer	0.0104	0.0252	CbGeAlD
Acetazolamide—CA6—head—muscle cancer	0.0104	0.0251	CbGeAlD
Acetazolamide—Sensory loss—Vincristine—muscle cancer	0.0101	0.0171	CcSEcCtD
Acetazolamide—CA3—head—muscle cancer	0.00981	0.0238	CbGeAlD
Acetazolamide—CA3—testis—muscle cancer	0.00948	0.023	CbGeAlD
Acetazolamide—Aplastic anaemia—Dactinomycin—muscle cancer	0.00915	0.0156	CcSEcCtD
Acetazolamide—CA9—testis—muscle cancer	0.00907	0.022	CbGeAlD
Acetazolamide—Tingling sensation—Etoposide—muscle cancer	0.00878	0.0149	CcSEcCtD
Acetazolamide—Numbness—Etoposide—muscle cancer	0.00851	0.0145	CcSEcCtD
Acetazolamide—Appetite absent—Methotrexate—muscle cancer	0.00849	0.0144	CcSEcCtD
Acetazolamide—CA5B—cardiac atrium—muscle cancer	0.00834	0.0202	CbGeAlD
Acetazolamide—CA1—renal system—muscle cancer	0.00822	0.02	CbGeAlD
Acetazolamide—Sensory loss—Etoposide—muscle cancer	0.00814	0.0138	CcSEcCtD
Acetazolamide—Urine output increased—Vincristine—muscle cancer	0.00787	0.0134	CcSEcCtD
Acetazolamide—Hepatic failure—Dactinomycin—muscle cancer	0.00787	0.0134	CcSEcCtD
Acetazolamide—CA5B—tendon—muscle cancer	0.00727	0.0176	CbGeAlD
Acetazolamide—Polyuria—Vincristine—muscle cancer	0.0072	0.0122	CcSEcCtD
Acetazolamide—CA2—embryo—muscle cancer	0.00704	0.0171	CbGeAlD
Acetazolamide—Hepatic failure—Vincristine—muscle cancer	0.00703	0.012	CcSEcCtD
Acetazolamide—CA12—head—muscle cancer	0.00695	0.0169	CbGeAlD
Acetazolamide—CA5B—vagina—muscle cancer	0.00675	0.0164	CbGeAlD
Acetazolamide—CA4—renal system—muscle cancer	0.00643	0.0156	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00637	0.0108	CcSEcCtD
Acetazolamide—Hyponatraemia—Vincristine—muscle cancer	0.00635	0.0108	CcSEcCtD
Acetazolamide—CA5B—head—muscle cancer	0.00623	0.0151	CbGeAlD
Acetazolamide—CA1—bone marrow—muscle cancer	0.00622	0.0151	CbGeAlD
Acetazolamide—CA5B—testis—muscle cancer	0.00602	0.0146	CbGeAlD
Acetazolamide—Ataxia—Vincristine—muscle cancer	0.00594	0.0101	CcSEcCtD
Acetazolamide—CA4—cardiac atrium—muscle cancer	0.00576	0.014	CbGeAlD
Acetazolamide—CA2—smooth muscle tissue—muscle cancer	0.00554	0.0134	CbGeAlD
Acetazolamide—CA1—head—muscle cancer	0.0055	0.0134	CbGeAlD
Acetazolamide—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00541	0.00919	CcSEcCtD
Acetazolamide—CA2—renal system—muscle cancer	0.00533	0.0129	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Etoposide—muscle cancer	0.00529	0.009	CcSEcCtD
Acetazolamide—Agranulocytosis—Dactinomycin—muscle cancer	0.00509	0.00865	CcSEcCtD
Acetazolamide—CA4—tendon—muscle cancer	0.00502	0.0122	CbGeAlD
Acetazolamide—Photosensitivity reaction—Vincristine—muscle cancer	0.00499	0.00848	CcSEcCtD
Acetazolamide—CA4—bone marrow—muscle cancer	0.00486	0.0118	CbGeAlD
Acetazolamide—CA2—cardiac atrium—muscle cancer	0.00477	0.0116	CbGeAlD
Acetazolamide—Erythema multiforme—Dactinomycin—muscle cancer	0.00463	0.00787	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00461	0.00784	CcSEcCtD
Acetazolamide—Flushing—Dactinomycin—muscle cancer	0.00454	0.00772	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—muscle cancer	0.00452	0.00768	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—muscle cancer	0.00448	0.00762	CcSEcCtD
Acetazolamide—Blood disorder—Doxorubicin—muscle cancer	0.00438	0.00745	CcSEcCtD
Acetazolamide—Hypoaesthesia—Vincristine—muscle cancer	0.00435	0.0074	CcSEcCtD
Acetazolamide—CA4—head—muscle cancer	0.0043	0.0104	CbGeAlD
Acetazolamide—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00416	0.00708	CcSEcCtD
Acetazolamide—CA2—tendon—muscle cancer	0.00416	0.0101	CbGeAlD
Acetazolamide—CA4—testis—muscle cancer	0.00415	0.0101	CbGeAlD
Acetazolamide—Melaena—Methotrexate—muscle cancer	0.00413	0.00702	CcSEcCtD
Acetazolamide—CA2—bone marrow—muscle cancer	0.00403	0.00978	CbGeAlD
Acetazolamide—Aplastic anaemia—Methotrexate—muscle cancer	0.00397	0.00675	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00395	0.00672	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00391	0.00665	CcSEcCtD
Acetazolamide—CA2—vagina—muscle cancer	0.00386	0.00937	CbGeAlD
Acetazolamide—Malaise—Dactinomycin—muscle cancer	0.00384	0.00653	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—muscle cancer	0.00382	0.0065	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—muscle cancer	0.00381	0.00649	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Etoposide—muscle cancer	0.00373	0.00635	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—muscle cancer	0.00368	0.00626	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—muscle cancer	0.00358	0.00609	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—muscle cancer	0.00357	0.00608	CcSEcCtD
Acetazolamide—CA2—head—muscle cancer	0.00357	0.00866	CbGeAlD
Acetazolamide—Hypoaesthesia—Etoposide—muscle cancer	0.00352	0.00599	CcSEcCtD
Acetazolamide—Agitation—Vincristine—muscle cancer	0.0035	0.00595	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—muscle cancer	0.00349	0.00594	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—muscle cancer	0.00349	0.00594	CcSEcCtD
Acetazolamide—CA2—testis—muscle cancer	0.00345	0.00836	CbGeAlD
Acetazolamide—CYP3A4—renal system—muscle cancer	0.00344	0.00835	CbGeAlD
Acetazolamide—Aplastic anaemia—Doxorubicin—muscle cancer	0.00344	0.00584	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—muscle cancer	0.00341	0.0058	CcSEcCtD
Acetazolamide—Leukopenia—Vincristine—muscle cancer	0.00341	0.00579	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—muscle cancer	0.0034	0.00579	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—muscle cancer	0.00335	0.0057	CcSEcCtD
Acetazolamide—Convulsion—Vincristine—muscle cancer	0.0033	0.00561	CcSEcCtD
Acetazolamide—Flushing—Etoposide—muscle cancer	0.00329	0.00559	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00317	0.00539	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vincristine—muscle cancer	0.00311	0.00528	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vincristine—muscle cancer	0.00304	0.00517	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00304	0.00517	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—muscle cancer	0.00302	0.00514	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—muscle cancer	0.00302	0.00514	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—muscle cancer	0.00302	0.00514	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—muscle cancer	0.003	0.0051	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—muscle cancer	0.00296	0.00503	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—muscle cancer	0.00293	0.00498	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—muscle cancer	0.00288	0.0049	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—muscle cancer	0.00287	0.00487	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—muscle cancer	0.00286	0.00487	CcSEcCtD
Acetazolamide—Paraesthesia—Vincristine—muscle cancer	0.00279	0.00474	CcSEcCtD
Acetazolamide—Malaise—Etoposide—muscle cancer	0.00278	0.00473	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00276	0.0047	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—muscle cancer	0.00276	0.00469	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—muscle cancer	0.00275	0.00467	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00274	0.00467	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—muscle cancer	0.00272	0.00463	CcSEcCtD
Acetazolamide—Decreased appetite—Vincristine—muscle cancer	0.0027	0.00459	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00268	0.00456	CcSEcCtD
Acetazolamide—Fatigue—Vincristine—muscle cancer	0.00268	0.00456	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—muscle cancer	0.00267	0.00454	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—muscle cancer	0.00267	0.00453	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—muscle cancer	0.00259	0.00441	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—muscle cancer	0.00254	0.00432	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—muscle cancer	0.00252	0.00428	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—muscle cancer	0.0025	0.00425	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—muscle cancer	0.00249	0.00424	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—muscle cancer	0.00246	0.00419	CcSEcCtD
Acetazolamide—Body temperature increased—Vincristine—muscle cancer	0.00246	0.00418	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—muscle cancer	0.00242	0.00411	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—muscle cancer	0.00242	0.00411	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00239	0.00407	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—muscle cancer	0.00238	0.00405	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—muscle cancer	0.00236	0.00402	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00234	0.00398	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—muscle cancer	0.00226	0.00384	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—muscle cancer	0.00225	0.00383	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—muscle cancer	0.00224	0.0038	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—muscle cancer	0.00224	0.0038	CcSEcCtD
Acetazolamide—Asthenia—Vincristine—muscle cancer	0.00223	0.00379	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—muscle cancer	0.00221	0.00376	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—muscle cancer	0.00221	0.00375	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—muscle cancer	0.00219	0.00372	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00217	0.00369	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—muscle cancer	0.00217	0.00369	CcSEcCtD
Acetazolamide—Diarrhoea—Vincristine—muscle cancer	0.00213	0.00361	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0021	0.00356	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—muscle cancer	0.00207	0.00353	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—muscle cancer	0.00207	0.00351	CcSEcCtD
Acetazolamide—Dizziness—Vincristine—muscle cancer	0.00205	0.00349	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—muscle cancer	0.00205	0.00348	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00203	0.00345	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—muscle cancer	0.00201	0.00341	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—muscle cancer	0.002	0.0034	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—muscle cancer	0.00199	0.00338	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—muscle cancer	0.00198	0.00336	CcSEcCtD
Acetazolamide—Vomiting—Vincristine—muscle cancer	0.00198	0.00336	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—muscle cancer	0.00195	0.00332	CcSEcCtD
Acetazolamide—Headache—Vincristine—muscle cancer	0.00195	0.00331	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00194	0.00329	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—muscle cancer	0.00191	0.00325	CcSEcCtD
Acetazolamide—Nausea—Vincristine—muscle cancer	0.00185	0.00314	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00183	0.00311	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—muscle cancer	0.00181	0.00308	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—muscle cancer	0.00181	0.00307	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—muscle cancer	0.00174	0.00295	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—muscle cancer	0.00172	0.00293	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—muscle cancer	0.00171	0.00291	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—muscle cancer	0.00171	0.00291	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—muscle cancer	0.00171	0.0029	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—muscle cancer	0.00167	0.00283	CcSEcCtD
Acetazolamide—Dizziness—Etoposide—muscle cancer	0.00166	0.00283	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—muscle cancer	0.00165	0.00281	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—muscle cancer	0.0016	0.00272	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—muscle cancer	0.0016	0.00272	CcSEcCtD
Acetazolamide—Headache—Etoposide—muscle cancer	0.00158	0.00268	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—muscle cancer	0.00157	0.00266	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—muscle cancer	0.00155	0.00264	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—muscle cancer	0.00152	0.00258	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—muscle cancer	0.00151	0.00256	CcSEcCtD
Acetazolamide—Nausea—Etoposide—muscle cancer	0.00149	0.00254	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00148	0.00252	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—muscle cancer	0.00148	0.00251	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—muscle cancer	0.00147	0.0025	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—muscle cancer	0.00144	0.00245	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—muscle cancer	0.00143	0.00243	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—muscle cancer	0.00139	0.00236	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—muscle cancer	0.00135	0.0023	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—muscle cancer	0.00135	0.00229	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—muscle cancer	0.00134	0.00228	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—muscle cancer	0.00133	0.00226	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—muscle cancer	0.00132	0.00224	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—muscle cancer	0.00131	0.00223	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00131	0.00222	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0013	0.00221	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—muscle cancer	0.0013	0.00221	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—muscle cancer	0.00128	0.00218	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—muscle cancer	0.00128	0.00217	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—muscle cancer	0.00124	0.00211	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—muscle cancer	0.0012	0.00204	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—muscle cancer	0.00119	0.00203	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—muscle cancer	0.00117	0.00199	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—muscle cancer	0.00116	0.00197	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—muscle cancer	0.00115	0.00195	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—muscle cancer	0.00113	0.00193	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00113	0.00192	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—muscle cancer	0.00113	0.00191	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—muscle cancer	0.00108	0.00184	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—muscle cancer	0.00108	0.00183	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—muscle cancer	0.00104	0.00176	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—muscle cancer	0.00103	0.00175	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—muscle cancer	0.00103	0.00175	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—muscle cancer	0.000997	0.0017	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—muscle cancer	0.000959	0.00163	CcSEcCtD
Acetazolamide—Headache—Methotrexate—muscle cancer	0.000944	0.00161	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—muscle cancer	0.000937	0.00159	CcSEcCtD
Acetazolamide—Nausea—Methotrexate—muscle cancer	0.000895	0.00152	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—muscle cancer	0.000893	0.00152	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—muscle cancer	0.000863	0.00147	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—muscle cancer	0.00083	0.00141	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—muscle cancer	0.000818	0.00139	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—muscle cancer	0.000775	0.00132	CcSEcCtD
